These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2379971)

  • 1. Treatment of acute liver failure with hemodetoxification techniques.
    Splendiani G; Tancredi M; Daniele M; Giammaria U
    Int J Artif Organs; 1990 Jun; 13(6):370-4. PubMed ID: 2379971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute hepatic failure with encephalopathy: a review.
    Ash SR
    Int J Artif Organs; 1991 Apr; 14(4):191-5. PubMed ID: 2060985
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental artificial liver support with emphasis on fulminant hepatic failure: concepts and review.
    Chang TM
    Semin Liver Dis; 1986 May; 6(2):148-58. PubMed ID: 3529408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-permeability membrane hemodialysis and hemofiltration in acute hepatic coma: experimental and clinical results.
    Opolon P
    Artif Organs; 1979 Nov; 3(4):354-60. PubMed ID: 533427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of support systems used in the management of fulminant hepatic failure.
    McGuire BM; Sielaff TD; Nyberg SL; Hu MY; Cerra FB; Bloomer JR
    Dig Dis; 1995; 13(6):379-88. PubMed ID: 8590524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurologic improvement of patients with hepatic failure and coma during sorbent suspension dialysis.
    Ash SR; Blake DE; Carr DJ; Carter C; Howard T; Makowka L
    ASAIO Trans; 1991; 37(3):M332-4. PubMed ID: 1751174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis versus cross hemodialysis in experimental hepatic coma.
    Opolon P; Lavallard MC; Huguet C; Bidallier M; Granger A; Gallot D; Bloch P
    Surg Gynecol Obstet; 1976 Jun; 142(6):845-53. PubMed ID: 936027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effective continuous hemofiltration and plasma exchange for the treatment of subacute type fulminant hepatic failure].
    Ogawa R; Kishikawa T; Kudo J; Inaba S; Takamatsu Y; Hirata Y; Yoshimatsu H; Ishibashi H; Taniyama T; Zaitsu A
    Fukuoka Igaku Zasshi; 1992 Aug; 83(8):338-42. PubMed ID: 1398429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in artificial liver for blood purification].
    Kodama M; Oka T; Tani T; Hanazawa K
    Nihon Rinsho; 1985 Dec; 43(12):2605-10. PubMed ID: 3915024
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic effects of blood purification in treatment of fulminant hepatic failure.
    Pu Y; Yang D; Mao Y; Zhang Y; Chen K
    Braz J Infect Dis; 2013; 17(4):427-30. PubMed ID: 23810709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane.
    Denis J; Opolon P; Nusinovici V; Granger A; Darnis F
    Gut; 1978 Sep; 19(9):787-93. PubMed ID: 710967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT).
    Ash SR; Blake DE; Carr DJ; Carter C; Howard T; Makowka L
    Int J Artif Organs; 1992 Mar; 15(3):151-61. PubMed ID: 1521900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute hepatic failure by hemoperfusion over baboon and human livers: alphafetoprotein levels in serum.
    Gundermann KJ; Lie TS
    Artif Organs; 1980 Feb; 4(1):27-9. PubMed ID: 6154453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A detoxification scheme for liver assist utilizing plasmapheresis, bioincompatible sorbents and dialysis.
    Maini R
    Artif Organs; 1979 May; 3(2):153-5. PubMed ID: 533399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effectiveness of sustained low-efficiency hemodialysis plus hemoperfusion and continuous hemofiltration plus hemoperfusion for acute severe organophosphate poisoning.
    Hu SL; Wang D; Jiang H; Lei QF; Zhu XH; Cheng JZ
    Artif Organs; 2014 Feb; 38(2):121-4. PubMed ID: 23957329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potentials of purification methods for the treatment of acute hepatic coma].
    Simeonov P
    Vutr Boles; 1981; 20(5):1-6. PubMed ID: 7034373
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical aspects and applications of hemofiltration.
    Weiss LG
    Scand J Urol Nephrol Suppl; 1989; 118():1-64. PubMed ID: 2785286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of reliable artificial liver support (ALS)--plasma exchange in combination with hemodiafiltration using high-performance membranes.
    Yoshiba M; Sekiyama K; Iwamura Y; Sugata F
    Dig Dis Sci; 1993 Mar; 38(3):469-76. PubMed ID: 8444078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble liver extract as supplement to detoxification by hemoperfusion in liver failure.
    Dixit V; Chang TM
    Int J Artif Organs; 1981 Nov; 4(6):291-4. PubMed ID: 7333688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous liver hemoperfusion and hemodialysis for treatment of hepatic coma and hepatorenal failure.
    Abouna GM
    Surgery; 1973 Apr; 73(4):541-9. PubMed ID: 4734761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.